1. Evaluate Pharma; internal estimates 2. flutiform® is a registered trade mark of Jagotec AG (in some territories, owned by Mundipharma AG). K-haler® is a registered trade mark of Mundipharma AG. 3. Registered trade marks of Novartis AG 4. Breelib™ is a registered trade mark of Bayer Intellectual Property GmbH 5. Registered trade marks of Glaxo Group Ltd. Formulation technology licence, product not developed by Vectura.
Track Record
Our combination of formulation science, device technology and inhaled development expertise has contributed to the success of 13 inhaled medicines, launched by our partners and licensees. Since launch, they have generated $11 billion in sales and in 2020 these products were used by 10 million patients worldwide.
$11bn
sales since launch
10m
patients treated worldwide
Our Track Record
1. Evaluate Pharma; internal estimates 2. flutiform® is a registered trade mark of Jagotec AG (in some territories, owned by Mundipharma AG). K-haler® is a registered trade mark of Mundipharma AG. 3. Registered trade marks of Novartis AG 4. Breelib™ is a registered trade mark of Bayer Intellectual Property GmbH 5. Registered trade marks of Glaxo Group Ltd. Formulation technology licence, product not developed by Vectura.